EULAR recommendations for the management of antiphospholipid syndrome in adults

Cited by (1,254)

Items 601–700 of 1,254

1. Distinctive cerebral small vessel disease patterns are associated with ischemic stroke in systemic lupus erythematosus
   Guilherme Diogo Silva, Germana T Vieira, Carolina de Medeiros Rimkus · 2025 · Lupus
2. NK cell dysfunction in antiphospholipid syndrome
   Anush Martirosyan, Eva Kriegová, Gayane P. Manukyan · 2025 · Frontiers in Immunology
3. Case Report: Failure of eculizumab to block complement to prevent relapse of anti-phospholipid syndrome in kidney transplant recipient
   Thibault Laban, Frederic Pigneur, Constance Guillaud et al. · 2025 · Frontiers in Nephrology
4. Abdominal pain in the patient with antiphospholipid antibody syndrome: A case report
   Haleh Pak, Armin Tajik, Ali Soltanian · 2019 · Clinical Case Reports
5. Primary antiphospholipid syndrome, Addison disease, and adrenal incidentaloma
   Gabriela Medina, María Pilar Jiménez-Arellano, Andrés Muñoz-Solís · 2020 · Clinical Rheumatology
6. Rare pulmonary embolism caused by the combination of bilateral popliteal venous aneurysms and antiphospholipid syndrome
   Tomoki Fukui, Nobuyuki Ogasawara, Shinji Hasegawa · 2020 · BMJ Case Reports
7. Case of an unusual diagnosis of primary antiphospholipid syndrome with multiple clinical complications
   Stathis Tsiakas, Chrysanthi Skalioti, Paraskevi Kotsi · 2020 · Oxford Medical Case Reports
8. Respiratory RNA Viruses: How to Be Prepared for an Encounter with New Pandemic Virus Strains
   Sergey V. Chepur, Pluzhnikov Nn, O. V. Chubar, Бакулина Лариса Сергеевна, Igor Litvinenko, Vadim Makarov, A. S. Gogolevsky, Vadim A. Myasnikov, I. A. Myasnikova, Ruslan Ismailovich Al-Shekhadat · 2021 · Biology Bulletin Reviews
9. Anticoagulation and Stroke
   Gisela Tinone, Maurício Hoshino, Leandro Tavares Lucato, Luiz Roberto Comerlatti · 2022 · Arquivos de Neuro-Psiquiatria
10. Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Anastasiia A. Shumilova, Kamila S. Nurbaeva, Mariya V. Cherkasova, Aleksander M. Lila, Evgeny Lvovich Nasonov · 2022 · Rheumatology Science and Practice
11. Choice of anticoagulation in patients with low risk antiphospholipid syndrome
    Brianna R. Bakow, Quan H. Phung, David Rabinovich · 2023 · Journal of Thrombosis and Thrombolysis
12. Catastrophic antiphospholipid syndrome: current aspects of pathogenesis, diagnosis and treatment
    А. А. Клименко, A. S. Gaffarova, Демидова Наталья Александровна · 2023 · Modern Rheumatology Journal
13. Can anticoagulation be withdrawn in APS patients after aPL negativization?
    María José Cuadrado, Anǵela Tincani, Eugenia Enríquez Merayo · 2023 · Autoimmunity Reviews
14. A review on management of antiphospholipid syndrome in clinical practice
    Carmine Siniscalchi, Pietro Rossetti, Gaetano Carolla, Pierpaolo Di Micco, Adriano Stella, Michele Augusto Riva · 2023 · Italian Journal of Medicine
15. Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools
    George C Drosos, George D. Konstantonis, Petros Paul Sfikakis · 2023 · RMD Open
16. Efficient removal of hydroxychloroquine sulfate using cocoa shell activated carbon: a green approach investigating equilibrium, kinetics, and thermodynamics
    Fayçal Finnouche, Amel Hamadi, Hiba Kais · 2024 · Journal of Dispersion Science and Technology
17. Viewpoint: Provoked thrombosis in antiphospholipid syndrome
    Denis G. Wahl, Vittorio Pengo · 2024 · Rheumatology
18. Primary antiphospholipid syndrome in a male presents with acute digital ischemia: Dramatic response to glucocorticoid
    Tanvir Ahammed, Mohammad Rasel, Sourav Taru Saha · 2024 · Clinical Case Reports
19. Antiphospholipid antibodies and antiphospholipid syndrome
    Rasmus Søgaard Hansen, Julie Brogaard Larsen, Pernille Just Vinholt, Anne Voss, Anders Mønsted Abildgaard · 2024 · Ugeskrift for Læger
20. Plasma cell-free DNA as a monitoring tool for high-risk pregnancies associated with antiphospholipid syndrome
    Julieta Cepeda, María Emilia Racca, María Alejandra Cardozo · 2024 · Thrombosis Research
21. Antiphospholipid syndrome
    Savino Sciascia, Massimo Radin, Karen Ingrid Schreiber · 2024 · Elsevier eBooks
22. Pregnancy planning in lupus and APS patients
    Isabell Haase, Rebecca Fischer‐Betz · 2024 · Frontiers in Lupus
23. Artificial intelligence meets the world experts; updates and novel therapies in autoimmunity - The 14th international congress on autoimmunity 2024 (AUTO14), Ljubljana
    Naim Mahroum, Abdulrahman Elsalti, Maisam Al Shawaf, Mohammad Darkhabani, Abdulrahman Alwani, Ravend Seida, Muhammet Tayfur Ertas, Ayse Gulnihan Simsek, Mustafa Awad, Mona Habra et al. · 2024 · Autoimmunity Reviews
24. Improving diagnosis in patients with obstetric antiphospholipid syndrome through the evaluation of non‐criteria antibodies
    Daniel Álvarez, Hephzibah E. Winter, Carlos Jaime Velásquez Franco · 2024 · Clinical & Translational Immunology
25. Diagnosis and management of antiphospholipid syndrome
    Yeri Ahn, Carolyn A. Hawkins, Eliza Pearson, Paul A. Kubler · 2024 · Australian Prescriber
26. Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke
    Wookjin Yang, Matthew J. Chung, Jiyeon Ha, Dong‐Wan Kang, Eung‐Joon Lee, Han‐Yeong Jeong, Jeong‐Min Kim, Keun‐Hwa Jung, Seung‐Hoon Lee · 2025 · Scientific Reports
27. Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Criteria on Retinal Vein Occlusion Patients
    Rafael Gálvez Sánchez, Zaida Salmón, Magdalena Fernández García, Andrea Cerveró, Belén González-Mesones-Galán, Marcos López‐Hoyos, Víctor Manuel Martínez-Taboada, José L. Hernández · 2025 · Journal of Clinical Medicine
28. Managing pregnancy-associated clinical emergencies in systemic lupus erythematosus: a case-based approach
    May Y. Choi, Erin Butler, Ann Elaine Clarke, Louis Girard, Paul Gibson, Leslie Skeith · 2019 · Expert Review of Clinical Immunology
29. Place actuelle des anticoagulants oraux directs dans la maladie thromboembolique veineuse
    A. Roffé, Alexis F. Guédon, E. Lallmahomed · 2021 · La Revue de Médecine Interne
30. State of the Art: Fertilität und Schwangerschaft bei rheumatischen Erkrankungen
    Isabell Haase, Rebecca Fischer‐Betz · 2021 · Zeitschrift für Rheumatologie
31. Schwangerschaft bei rheumatischen Erkrankungen
    Rebecca Fischer‐Betz, Susanna Späthling‐Mestekemper · 2019 · Zeitschrift für Rheumatologie
32. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis
    Olga Yu. Tkachenko, Sergey Vladimirovich Lapin, A. V. Маzing, Vladimir Leonidovich Emanuel, E. Belolipetskaia, И Б Беляева, Valentina Yu. Myachikova, А. L. Maslyanskiy, Boris Gilburd, Peter Schierack et al. · 2020 · Lupus
33. Antiphospholipid syndrome and challenges with direct oral anticoagulants
    Stephen W. Booth, Kieran Burton, Beverley Jane Hunt, Michael Desborough · 2020 · British Journal of Hospital Medicine
34. Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review
    Yulan Chen, Haitao Yang, Li-Xiong Liu, Cui-Hong Chen, Huang Qin, Xiaoping Hong, Jiuliang Zhao, Dongzhou Liu · 2020 · Clinical Rheumatology
35. Addison's disease in antiphospholipid syndrome: A rare complication
    Farzaneh Yazdi, Mohammad Reza Shakibi, Hanieh Mirkamali · 2021 · Clinical Case Reports
36. The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis—A Two-Year Prospective Study
    Katja Perdan Pirkmajer, Polona Žigon, Anja Boc, Eva Podovšovnik, Saša Čučnik, Alenka Mavri, Žiga Rotar, Aleš Ambrožič · 2021 · Biomedicines
37. Synthesis and pharmacological evaluation of choroquine derivatives bearing long aminated side chains as antivirus and anti-inflammatory agents
    Zilan Song, Yuting Liu, Cheng-Hu Xie · 2021 · Bioorganic Chemistry
38. Pregnancy Counseling in Rheumatic Diseases: Where Science Meets the Steps
    Anu Balakrishnan, Pankti Mehta, Latika Gupta · 2020 · Indian Journal of Rheumatology
39. The antiphospholipid syndrome
    Giuseppe Barilaro, Gerard Espinosa, Ricard Cervera · 2021 · Revista Colombiana de Reumatología
40. Prevalence of antiphospholipid antibody syndrome misclassification in an academic health system
    Madison Ballif, Sara R. Vazquez, JOHN B. DEC. M. SAUNDERS · 2022 · Thrombosis Research
41. Frequency and clinical outcomes of pharmacist-driven switching from warfarin to direct oral anticoagulants in an underserved patient population: A retrospective cohort study
    Rebekah R Bartholomew, Brie N. Noble, Jennifer J Stanislaw · 2022 · American Journal of Health-System Pharmacy
42. Early HELLP Syndrome or Catastrophic Antiphospholipid Syndrome? A Diagnostic Dilemma
    Suhwoo Bae, Lizelle Comfort, Jason Ng · 2023 · Cureus
43. Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults‘
    Rui Gao, Lang Qin · 2021 · Annals of the Rheumatic Diseases
44. European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria—documenting progress in lupus
    Martin Aringer, Maria G. Tektonidou, Dimitrios T. Boumpas · 2020 · Lara D. Veeken
45. What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?
    Guillermo Ruiz‐Irastorza, Munther A. Khamashta · 2022 · Expert Review of Clinical Immunology
46. Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
    Antonino Tuttolomondo, Pasquale Pignatelli, Roberto Pola · 2023 · Frontiers in Cardiovascular Medicine
47. Antiphospholipid Syndrome and the Kidney
    Maxime Taghavi, Lucas Jacobs, Dario Roccatello · 2025 · Kidney International Reports
48. Why do patients with antiphospholipid syndrome bleed? A clinical paradox
    María Cynthia Fuentes-Lacouture, Lizeth Bustamante Gómez, Nicolás Torres · 2023 · Blood Coagulation & Fibrinolysis
49. Impact of thrombophilia on venous thromboembolism management
    Joseph Emmerich, Stéphane Zuily, Isabelle Gouin‐Thibault, Pierre‐Emmanuel Morange, Françis Couturaud, Menno Volkert Huisman · 2024 · La Presse Médicale
50. Is it time for treat-to-target in antiphospholipid syndrome?
    Savino Sciascia, Giuseppe Barilaro, Massimo Radin, Ricard Cervera, Dario Roccatello · 2024 · Autoimmunity Reviews
51. Medication-related hospitalisations in patients with SLE
    Michèle Stanciu, Jack Oliver Lee, Emily Gibson McDonald · 2025 · Lupus Science & Medicine
52. Longitudinal assessment of cerebral infarcts and small vessel disease using magnetic resonance imaging in antiphospholipid syndrome: A single‐centre retrospective study
    Yishi Tan, Andrew J. Doyle, Jayant Kumar, Peter Somerville, Uzma Faruqi, Anicee Danaee, Pu‐Lin Luo, Beverley Jane Hunt, Karen A. Breen · 2025 · eJHaem
53. Mechanisms and roles of hydroxychloroquine in pregnancy in rheumatic diseases
    Lingjun Kong, Qian Wang, Yanan He, Wen Zhang · 2025 · Annals of the Academy of Medicine Singapore
54. Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome
    Lieve Van Hoovels, Silvia Piantoni, Els Bailleul, Sofie Schouwers, Massimo Radin, Maria Infantino, Emirena M. Garrafa, Bo Massa, Siska Blomme, Stefanie Van den Bremt et al. · 2025 · Journal of Thrombosis and Haemostasis
55. Lupus Anticoagulant Testing in Challenging Situations: Navigating Complexities
    Devreese, Katrien M. J. · 2026 · International Journal of Laboratory Hematology
56. Epigenetic regulation of thrombo-inflammation in Behçet and antiphospholipid syndrome
    Alessandra Bettiol, Giacomo Bagni, Francesca Di Patti · 2025 · Journal of Translational Autoimmunity
57. Detection of moderate to high antiphospholipid antibodies by chemiluminescence meets 2023 APS classification criteria
    Haiyue Jiang, Yaqing Yang, Zihan Tang, Haoyu Pan, Honglei Liu, Xiaobing Cheng, Yutong Su, Junna Ye, Qiongyi Hu, Jianfen Meng et al. · 2025 · Scientific Reports
58. Autoimmune Diseases and Pregnancy – Is There a Greater Risk of Giving Birth to a Sick Child?
    Magdalena Pszczołowska, Kamil Walczak, Weronika Kołodziejczyk, Magdalena Mroziak, Gracjan Kozłowski, Jerzy Leszek · 2025 · Archivum Immunologiae et Therapiae Experimentalis
59. A disrupted adenosinergic axis facilitates platelet activation in APS: exploring a novel therapeutic target
    Somanathapura K. NaveenKumar, Thalia G. Newman, Bruna de Moraes Mazetto et al. · 2025 · Blood Advances
60. Antiphospholipid Syndrome—Diagnostic and Methodologic Approach
    Agata Stańczewska, Karolina Szewczyk‐Golec, Iga Hołyńska-Iwan · 2025 · Metabolites
61. The distinct subtypes and prognosis of acute myocardial infarction in antiphospholipid syndrome patients
    Can Liang Huang, Yuan Zhao, Hui Jiang, Yangzhong Zhou, Chaojun Hu, Xiaoxiao Guo, Mengtao Li, Xiaofeng Zeng, Jiuliang Zhao · 2025 · Clinical Rheumatology
62. Laboratory Identification of Lupus Anticoagulant ( LA ) Using Different Activated Partial Thromboplastin Time ( APTT ) Assays
    Bárbara Gomes Barion, Bianca Stefanello, Maria Luiza S. A. de Paula, Thaís Siemerink Saraiva, Paula Ribeiro Villaça, Vanderson Rocha, Fernanda Andrade Orsi, Tânia Rúbia Flores da Rocha · 2025 · International Journal of Laboratory Hematology
63. Assessment of thrombophilia in patients with lupus anticoagulant
    Elena Pontara, Maria Grazia Cattini, Elisa Bison, Marta Tonello, Margherita Zen, Cristina Vicenzetto, Andrea Silvio Giordani, Anna Baritussio, Alida L.P. Caforio, Vittorio Pengo · 2025 · Thrombosis Research
64. Elevated pre-eclampsia risk in lupus nephritis and antiphospholipid syndrome: a nationwide Spanish registry analysis
    Mario Martín‐Portugués, Jorge Esteban‐Sampedro, Susana Mellor‐Pita et al. · 2025 · Lara D. Veeken
65. Development of a new scoring system for predicting recurrent thrombosis in patients with antiphospholipid syndrome
    Oh Chan Kwon, Jang Woo Ha, Min‐Chan Park, Yong‐Beom Park, Sang‐Won Lee · 2025 · Revista Brasileira de Reumatologia
66. IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications—A Scoping Review
    Monika Očková, Ariadna Anunciación-Llunell, Catalina Andrada, Enrique Esteve‐Valverde, Francesc Miró‐Mur, Jaume Alijotas‐Reig · 2025 · Journal of Clinical Medicine
67. 2025 Brazilian guidelines for the management of neuromyelitis optica spectrum disorder in adults and children
    Samira Luísa Apóstolos‐Pereira, Alfredo Damasceno, Ana Cláudia Piccolo, María Fernanda Mendes, Maria Lúcia Brito Ferreira, Regina Maria Papais Alvarenga, Bruna Klein da Costa, Douglas Kazutoshi Sato, Doralina Guimarães Brum, Elisa Matias Vieira de Melo et al. · 2025 · Arquivos de Neuro-Psiquiatria
68. Nanomedicine for venous thrombosis: Insights from an inflammatory perspective
    Qiu Zeng, Yuan Guo, Anyu Yang, Jun Li · 2025 · Biomaterials
69. Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome
    Pedro Gaspar, Ana Rita Cruz-Machado, Ana Mafalda Abrantes et al. · 2025 · Lara D. Veeken
70. Terrible APS — a newly defined variant of severe APS
    Stanley Niznik, Tania Zaher, Soad Haj Yahia, Ronen Shavit, Shiri Weinstein, Yulia Lifshitz, Nancy Agmon‐Levin · 2026 · Frontiers in Immunology
71. aPLs seroconversion in antiphospholipid syndrome: from definition to clinical relevance
    Angela Di Giorgio, Claudia Carnuccio, Antonio Nesci, Valerio De Stefano, Angelo Santoliquido · 2026 · Thrombosis Research
72. Hematologic disorders in pregnancy: the role of the complement system
    Charlotte McIlwaine Story, Shruti Chaturvedi, Gloria Frances Gerber · 2026 · Expert Review of Hematology
73. Postpartum challenges in women with systemic autoimmune diseases
    Dina Zucchi, Chiara Tani, Giancarlo Cascarano · 2026 · Frontiers in Lupus
74. Prospects for the treatment of systemic autoimmune rheumatic diseases. What intensive care physicians need to know
    Evgeny Lvovich Nasonov, M A Lysenko, Zinaida Yu. Mutovina, Загребнева Алена Игоревна, Ekaterina V. Nikolaeva, L. P. Ananyeva, Tatiana Valentinovna Beketova, Tatiana Magomedalievna Reshetnyak, Sergey K. Solovyev, Elena Aleksandrovna Aseeva et al. · 2026 · Rheumatology Science and Practice
75. The Asia Pacific League of Associations for Rheumatology ( APLAR ) Consensus Statements for the Management of Reproductive Issues in Autoimmune Rheumatic Diseases
    Vinod K. Ravindran, Madhuri H Radhakrishna, Sunitha Kayidhi et al. · 2026 · International Journal of Rheumatic Diseases
76. Treat-to-Target beim systemischen Lupus erythematodes
    Johanna Mücke, Christina Düsing, Gamal Chehab · 2020 · Zeitschrift für Rheumatologie
77. Monitoring and Dosing of Argatroban in a Patient With Antiphospholipid Syndrome
    Karli Dooling, Bradley J. Haan · 2020 · Hospital Pharmacy
78. Erkenntnisse zu Schwangerschaft und Stillzeit bei entzündlich rheumatischen Erkrankungen durch Beobachtungsdaten
    Yvette Meißner, Anja Strangfeld · 2021 · Zeitschrift für Rheumatologie
79. Highlights on HELLP syndrome
    Mathilde Pécourt · 2021 · JMV-Journal de Médecine Vasculaire
80. Immunomodulation in antiphospholipid-antibody-associated endocarditis: a case report and review of the literature
    Franz Haertel, Daniel Kretzschmar, Paul Christian Schulze · 2021 · European Heart Journal - Case Reports
81. Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS)
    Savino Sciascia, Silvia Grazietta Foddai, Cristiano Alessandri, Alessia Alunno, Laura Andréoli, Alice Barinotti, Antonia Calligaro, Valentina Canti, Francesco Carubbi, Irene Cecchi et al. · 2022 · Thrombosis and Haemostasis
82. Recurrent strokes and memory loss in a patient with triple-positive antiphospholipid antibody syndrome
    Chinenye Osuorji, Jawad Bilal, Ikenna Osuorji · 2022 · BMJ Case Reports
83. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis
    Aleksandra Djoković, Ljudmila Stojanovich, Nataša Stanisavljević, Predrag Matić, D. Colic, Daniel Škrijelj, Sandra Djokic, Branka F. Filipović · 2022 · JCR Journal of Clinical Rheumatology
84. Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021
    Chana Azzoug, G. Nuemi, Didier Menu, Emmanuel de Maistre, Mathieu Boulin, Alain Putot, Patrick Manckoundia · 2023 · International Journal of Environmental Research and Public Health
85. A Review of Systemic Hematological Manifestations and Stent Thrombosis
    Rachael Biggart, Claire R. Davies, Nikhil Vilas Joshi · 2023 · Cardiology in Review
86. A 25-Year-Old Woman with a High-Risk Large and Occlusive Pulmonary Embolism, Later Diagnosed with Primary Antiphospholipid Syndrome and Hyperhomocysteinemia: A Case Report
    Juan Manuel Muñoz Moreno, Anthony Ramos-Yataco, Emanuel Salcedo-Davila · 2023 · American Journal of Case Reports
87. Myocardial infarction in a 33-year-old with inflammatory bowel disease: a case report
    Christopher Paul Bengel, Denisa Müller-Gastell, Bassam Al-Najjar · 2023 · BMC Cardiovascular Disorders
88. Complications and outcomes of pregnancy in patients with antiphospholipid antibodies during various treatment methods
    Yu. S. Bagdasarova, М. С. Зайнулина, Mariya Gennadevna Nikolaeva · 2023 · Obstetrics Gynecology and Reproduction
89. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review
    José Antonio Girón-Ortega, J.A. Girón González · 2023 · Medicina Clínica (English Edition)
90. Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus Erythematosus
    Fariza A. Cheldieva, Tatiana Magomedalievna Reshetnyak, Anastasiia A. Shumilova, Kamila S. Nurbaeva, Mariya V. Cherkasova, Aleksander M. Lila, Evgeny Lvovich Nasonov · 2023 · Doklady Biochemistry and Biophysics
91. Embolic Phenomena of Libman-Sacks Endocarditis and Antiphospholipid Syndrome
    Asher Gorantla, Michael Schaible, Shruthi Sivakumar, Anandita Kishore, Wayne Andrew-Palmer, Selin Unal, Michael Ramírez, Varshitha Tumkur Panduranga, Adam S. Budzikowski · 2023 · Cureus
92. New classification criteria for antiphospholipid syndrome — 2023
    Jacek Musiał · 2023 · Journal of Transfusion Medicine
93. Eculizumab therapy and complement regulation in a case of resistant catastrophic antiphospholipid syndrome
    Rachel Frederick, Luigi Zolio, Evange Romas · 2024 · BMJ Case Reports
94. Risk Factors for Adverse Pregnancy Outcomes in Patients with Antiphospholipid Syndrome
    Yuke Hou, Lei Hou, Ziyi Song, Liang Luo, Jiayang Jin, Xuewu Zhang, Chun Li · 2024 · Clinical and Experimental Obstetrics & Gynecology
95. Antiphospholipid antibody-related hepatic vasculitis in a juvenile after non-severe COVID-19: a case report and literature review
    Qingyu Li, Jingya Li, Menglan Zhou, Ying Chun Ge, Zhengyin Liu, Taisheng Li, Li Zhang · 2024 · Frontiers in Immunology
96. Antiphospholipid Syndrome Increases Postoperative Complications After Total Hip and Knee Arthroplasty
    Ankit Hirpara, Melissa Carpenter, Michael R. Dayton, Craig A. Hogan · 2024 · Orthopedics
97. [Obstetric Antiphospholipid Syndrome: Insights on the Diagnosis, Treatment, and Hot Issues].
    Rui Gao, Lang Qin · 2024 · 四川大学学报：医学版
98. Added IMPACT: The first successful natural birth using certolizumab in obstetric APS
    Anastasia‐Vasiliki Madenidou, Hannah Kither, Sarah Dyball · 2024 · Thrombosis Research
99. Characteristics and prognosis of elderly-onset antiphospholipid syndrome: An observational cohort study
    Liang Luo, Qingmeng Cai, Xiangjun Liu, Zelin Yun, Xuerong Li, Rui Yan, Chun Li · 2024 · Lupus
100. Recurrent thrombotic events in pediatric antiphospholipid syndrome: A systematic review and meta-analysis
     Alexandra Zabeida, Alessandra Bosch, Elizabeth M. Uleryk, Laura Avila · 2024 · Thrombosis Research